Should you buy this stock after sales rose 20% in Q3?

Is a 20% rise in sales the beginning of big things for this company?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Third quarter results released today for speciality chemicals maker Croda (LSE: CRDA) saw sales jump a full 20.1% year-on-year to hit £315m. Unfortunately, management was very upfront about the fact that “with over 95% of sales outside the UK, this largely reflected favourable currency translation, with the impact of weaker sterling increasing sales by 17.6%.”

Stripping out the effects of the weaker pound, constant currency sales did rise 2.5% year-on-year due to the positive effects of an acquisition in Croda’s crop care division. However, core underlying sales dropped 2.5% on the back of falling sales of a major generic pharmaceutical ingredient.

Sales compressing is never a good sign and will be worth watching in the coming quarters. But, if underlying sales return to growth then Croda becomes very attractive. A major reason is that the company is well diversified by designing chemicals for everything from haircare, lipstick and sunscreen to seed treatments and environmentally-friendly paint coatings.

Developing and selling these products is also a very capital light business, which produces significant free cash flow. And, a cost-conscious management team and increasing sales of patented products allowed operating margins to improve to 25.7% in H1.

The impressive cash generated by these margins and tight control over capex allow Croda to make targeted acquisitions without resorting to high leverage. At the end of July the company’s net debt-to-EBITDA ratio was only 1.3, a very healthy level for such a cash generative business. This is allowing dividends to increase substantially, although a long rally in share prices means they only yield 2%. Croda is certainly an attractive company, and I believe the shares are worth following in the coming quarters.

Worth a look?

While Croda’s products focus on retail applications, another of the FTSE’s leading industrial firms, Elementis (LSE: ELM), concentrates on industrial applications for oil rigs, cargo ships and construction materials. Elementis has been hit hard by the downturn in the oil & gas industry, with revenue from this key segment down 26% in the first half of the year.

This dramatic fall in sales drove overall group revenue down by 7% year-on-year and led to operating margins collapsing from 19% to 15%. A decrease in oilfield activity isn’t the only headwind facing Elementis as the strong US dollar has negatively impacted sales in its chromium division and forced the company to issue a profit warning in June.

That said, its core business is quite impressive. Its operations still spin off significant cash, which management has no qualms about returning to shareholders due to having no debt. With net cash at the end of June standing at $37.5m, the company was able to maintain interim dividends even as earnings fell.

The twin headwinds facing Elementis, a struggling oil & gas sector and strong US dollar, aren’t about to stop any time soon. However, with a great underlying business, shares trading at a relatively sane level and dividends already yielding 3.3%, now could be the time for contrarian investors to take a closer look.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has recommended Elementis. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

If I put £750 into a SIPP every month, could I retire a millionaire?

Ben McPoland considers a high-quality FTSE 100 stock that could contribute towards building him a large SIPP portfolio in future.

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »